Weijia Fang

Edge Intelligence: The Confluence of Edge Computing and Artificial Intelligence

Shuiguang Deng, Hailiang Zhao, Weijia Fang et al. · IEEE Internet of Things Journal · 2020 · 1.1K citations · Full text

Computing, Computer Science, Computer Systems +16

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

Shukui Qin, Zhenggang Ren, Zhiqiang Meng et al. · The Lancet Oncology · 2020 · 638 citations

Medicine, Oncology, Pharmacology +9

Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma

Yi Zheng, Tingting Wang, Xiaoxuan Tu et al. · Journal for ImmunoTherapy of Cancer · 2019 · 528 citations · Full text

Life Sciences, Microbiology, Oncology +17

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Shukui Qin, Li Qiu, Shanzhi Gu et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 254 citations

Medicine, Oncology, Pharmacotherapy +10